Hikma Pharmaceutical | Eiendeler



Assets Endring Dato
Almirall EUR 2.32B 14.19M 2024-06
AstraZeneca USD 104.04B 887M 2024-12
Autolus Therapeutics Ltd 782.72M 44.76M 2024-12
Bayer EUR 110.85B 3.9B 2024-12
Fresenius EUR 43.55B 1.18B 2024-12
Galapagos EUR 4.02B 113.77M 2025-03
Genmab DKK 45.81B 6.15B 2024-12
GlaxoSmithKline GBP 59.46B 1.41B 2024-12
GRIFOLS EUR 21.41B 1.12B 2024-12
Hikma Pharmaceutical USD 4.85B 167M 2024-06
Lonza CHF 19.73B 1.85B 2024-12
Merck EUR 51.57B 1.42B 2024-12
Orion EUR 1.7B 72.7M 2025-03
Recordati EUR 4.2B 2.87M 2024-09
Roche Holding CHF 101.8B 6.02B 2024-12
Sanofi 131.89B 906M 2025-03
UCB EUR 17.35B 1.72B 2024-12



Hikma Pharmaceutical Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.